Movatterモバイル変換


[0]ホーム

URL:


ES2132076T3 - Pirroles sustituidos. - Google Patents

Pirroles sustituidos.

Info

Publication number
ES2132076T3
ES2132076T3ES91112829TES91112829TES2132076T3ES 2132076 T3ES2132076 T3ES 2132076T3ES 91112829 TES91112829 TES 91112829TES 91112829 TES91112829 TES 91112829TES 2132076 T3ES2132076 T3ES 2132076T3
Authority
ES
Spain
Prior art keywords
elevated
union
sum
pyq
alcali
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91112829T
Other languages
English (en)
Inventor
Peter David Davis
Christopher Huw Hill
Geoffrey Lawton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909017269Aexternal-prioritypatent/GB9017269D0/en
Priority claimed from GB919109959Aexternal-prioritypatent/GB9109959D0/en
Application filed by F Hoffmann La Roche AGfiledCriticalF Hoffmann La Roche AG
Application grantedgrantedCritical
Publication of ES2132076T3publicationCriticalpatent/ES2132076T3/es
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

COMPUESTOS DE LA FORMULA: DONDE R ELEVADO 1 Y R ELEVADO 3, CONJUNTAMENTE, FORMAN UNA UNION Y R (AL CUADRADO) REPRESENTA HIDROGENO O R ELEVADO 1 Y R (AL CUADRADO) , CONJUNTAMENTE, FORMAN UNA UNION Y R ELEVADO 3 REPRESENTA HIDROGENO; R ELEVADO 4, R ELEVADO 5, R ELEVADO 6 Y R ELEVADO 7 CADA UNO INDEPENDIENTEMENTE REPRESENTAN HIDROGENO, ALCALI, HALOALCALI, ALKOXI, NITRO, AMINO, ALKANOILAMINO, AROILAMINO, ALKILTIO O ALKILSULFONILO; R ELEVADO 8 REPRESENTA HIDROGENO, ALCALI O ARALKIL; X REPRESENTA -N(R ELEVADO 9)AL R ELEVADO 9, R ELEVADO 10 Y R ELEVADO 11 CADA UNO REPRESENTA HIDROGENO, ALCALI, ARALKIL O ALKANOIL; M REPRESENTA 0-2 Y N 1-3, CON LA CONDICION DE QUE LA SUMA DE M Y N SEA 1-3; P REPRESENTA 0-4 Y Q 0-4, CON LA CONDICION QUE LA SUMA DE P Y Q SEA 2-4 CUANDO X REPRESENTE -N(R ELEVADO 9)-, QUE LA SUMA DE P Y Q SEA 1-5 CUANDO X REPRESENTE -CHN(R ELEVADO 10, R ELEVADO 11)ELEVADO 1 Y R (AL CUADRADO) CONJUNTAMENTE FORMEN UNA UNION, QUE LA SUMA DE P Y Q SEA 0-4 CUANDO X REPRESENTE -N(R ELEVADO 9)-, R ELEVADO 1 Y R ELEVADO 3 CONJUNTAMENTE REPRESENTEN UNA UNION Y M REPRESENTE 0. ASI COMO SALES FARMACEUTICAMENTE ACEPTABLES DE COMPUESTOS ACIDICOS DE LA FORMULA I CON BASES Y DE COMPUESTOS BASICOS DE LA FORMULA I CON ACIDOS, SON UTILES PARA CONTROLAR Y PREVENIR DESORDENES INFLAMATORIOS, INMUNOLOGICOS, ONCOLOGICOS, BRONCOPULMONARES, DERMATOLOGICOS O CARDIOVASCULARES, O PARA EL TRATAMIENTO DEL ASMA, SIDA O COMPLICACIONES DIABETICAS O PARA LA ESTIMULACION DEL CRECIMIENTO DEL CABELLO. PUEDEN PREPARARSE DE LOS FURANDIONES SUSTITUIDOS CORRESPONDIENTES.
ES91112829T1990-08-071991-07-30Pirroles sustituidos.Expired - LifetimeES2132076T3 (es)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
GB909017269AGB9017269D0 (en)1990-08-071990-08-07Substituted pyrroles
GB919109959AGB9109959D0 (en)1991-05-081991-05-08Substituted pyrroles

Publications (1)

Publication NumberPublication Date
ES2132076T3true ES2132076T3 (es)1999-08-16

Family

ID=26297468

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ES91112829TExpired - LifetimeES2132076T3 (es)1990-08-071991-07-30Pirroles sustituidos.

Country Status (26)

CountryLink
EP (1)EP0470490B1 (es)
JP (1)JPH0780880B2 (es)
KR (1)KR100233964B1 (es)
AT (1)ATE179710T1 (es)
AU (1)AU649699B2 (es)
CA (1)CA2046801C (es)
CZ (1)CZ280359B6 (es)
DE (1)DE69131190T2 (es)
DK (1)DK0470490T3 (es)
DZ (1)DZ1521A1 (es)
ES (1)ES2132076T3 (es)
FI (1)FI95909C (es)
GR (1)GR3030677T3 (es)
HU (1)HU210547B (es)
IE (1)IE912787A1 (es)
IL (1)IL99064A (es)
IS (1)IS1682B (es)
MC (1)MC2279A1 (es)
MY (1)MY106400A (es)
NO (1)NO179143C (es)
NZ (1)NZ239216A (es)
PT (1)PT98583B (es)
RO (1)RO112724B1 (es)
RU (1)RU2075474C1 (es)
SK (1)SK279566B6 (es)
UA (1)UA27100A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
GB9123396D0 (en)*1991-11-041991-12-18Hoffmann La RocheA process for the manufacture of substituted maleimides
JPH07504673A (ja)*1992-03-201995-05-25ザ・ウエルカム・ファウンデーション・リミテッド抗ウイルス活性を有するインドール誘導体
AU678435B2 (en)1993-05-101997-05-29F. Hoffmann-La Roche AgSubstituted pyrroles
US5721230A (en)*1993-05-101998-02-24Hoffmann-La Roche Inc.Substituted pyrroles
US5405864A (en)*1993-10-151995-04-11Syntex (U.S.A.) Inc.Chemotherapeutic maleimides
US5624949A (en)*1993-12-071997-04-29Eli Lilly And CompanyProtein kinase C inhibitors
JP3581731B2 (ja)*1993-12-072004-10-27イーライ・リリー・アンド・カンパニープロテインキナーゼc阻害物質
US5541347A (en)*1993-12-071996-07-30Eli Lilly And CompanySynthesis of bisindolylmaleimides
FI945705L (fi)*1993-12-071996-06-03Lilly Co EliBisindolyylimaleimidien parannettu synteesi
US5723456A (en)*1993-12-071998-03-03Eli Lilly & CompanyTherapeutic treatment for cardiovascular diseases
US5843935A (en)*1993-12-071998-12-01Eli Lilly And CompanyProtein kinase C inhibitors
US6804058B1 (en)1993-12-212004-10-123M Innovative Properties CompanyElectroluminescent light source and display incorporating same
US6025897A (en)1993-12-212000-02-153M Innovative Properties Co.Display with reflective polarizer and randomizing cavity
DE69434294T2 (de)*1993-12-232005-12-29Eli Lilly And Co., IndianapolisProteinkinase c-inhibitoren
US5491242A (en)*1994-06-221996-02-13Eli Lilly And CompanyProtein kinase C inhibitors
US5481003A (en)*1994-06-221996-01-02Eli Lilly And CompanyProtein kinase C inhibitors
US5554608A (en)*1994-09-281996-09-10Ahluwalia; Gurpreet S.Inhibition of hair growth
CA2268399C (en)*1996-10-312008-08-19Harbor Branch Oceanographic Institution, Inc.Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
IL133212A (en)*1997-06-022005-12-18Janssen Pharmaceutica Nv History of use (imidazolil-5-yl) methyl-2-quinolinone that act as culture inhibitors of smooth muscle cells
DE19802708A1 (de)*1998-01-241999-07-29Hoechst Marion Roussel De GmbhVerwendung von hydroxypyridon-haltigen Puderzubereitungen zur Behandlung von Unterschenkel- und Druckgeschwüren
JP2002520315A (ja)1998-07-082002-07-09ハーバー ブランチ オーシャノグラフィック インスティテューション インク.ビスインドール誘導体および抗炎症剤としてのそれらの使用
GB9828640D0 (en)*1998-12-231999-02-17Smithkline Beecham PlcNovel method and compounds
FR2796274B1 (fr)*1999-07-162001-09-21OrealUtilisation de l'acide 4,6-dimethoxy-indole 2-carboxylique ou de ses derives pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US6281356B1 (en)*1999-12-222001-08-28Hoffmann-La Roche Inc.Substituted pyrroles
TW201041580A (en)2001-09-272010-12-01Alcon IncInhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma
CA2393720C (en)2002-07-122010-09-14Eli Lilly And CompanyCrystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride
TWI324604B (en)2003-06-182010-05-11Novartis AgNew use of staurosporine derivatives
AU2004262927B2 (en)2003-08-082008-05-22Novartis AgCombinations comprising staurosporines
US20070232658A1 (en)*2004-04-082007-10-04Jurgen WagnerProtein Kinase C Inhibitors for the Treatment of Autoimmune Diseases and of Transplant Rejiction
RU2413511C2 (ru)*2004-04-082011-03-10Новартис АгИнгибиторы протеинкиназы с, предназначенные для лечения аутоиммунных заболеваний и отторжения трансплантата
FR2870538B1 (fr)*2004-05-192006-07-14Servier LabNouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3741375A1 (en)2014-07-172020-11-25INSERM (Institut National de la Santé et de la Recherche Médicale)Methods for treating neuromuscular junction-related diseases
WO2016207366A1 (en)2015-06-262016-12-29INSERM (Institut National de la Santé et de la Recherche Médicale)Methods and pharmaceutical compositions for the treatment of viral infections

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
NZ227850A (en)*1988-02-101991-11-26Hoffmann La RocheIndole substituted pyrrole derivatives; preparatory process and medicaments for use against inflammatory immunological, bronchopulmonary or vascular disorders
MC2096A1 (fr)*1989-02-231991-02-15Hoffmann La RochePyrroles substitues
IL94274A0 (en)*1989-05-051991-03-10Goedecke AgMaleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same

Also Published As

Publication numberPublication date
SK279566B6 (sk)1999-01-11
IL99064A0 (en)1992-07-15
MC2279A1 (fr)1993-06-23
AU649699B2 (en)1994-06-02
GR3030677T3 (en)1999-11-30
NZ239216A (en)1994-05-26
IS1682B (is)1998-02-24
IE912787A1 (en)1992-02-12
HU210547B (en)1995-05-29
IL99064A (en)1995-08-31
JPH04230686A (ja)1992-08-19
RO112724B1 (ro)1997-12-30
HUT61542A (en)1993-01-28
NO179143C (no)1996-08-14
EP0470490B1 (en)1999-05-06
CS243591A3 (en)1992-02-19
RU2075474C1 (ru)1997-03-20
CA2046801A1 (en)1992-02-08
MY106400A (en)1995-05-30
HU912589D0 (en)1992-01-28
CZ280359B6 (cs)1995-12-13
AU8167291A (en)1992-02-13
PT98583A (pt)1992-06-30
DE69131190T2 (de)1999-11-04
DK0470490T3 (da)1999-11-01
IS3741A7 (is)1992-02-08
UA27100A1 (uk)2000-02-28
DZ1521A1 (fr)2004-09-13
DE69131190D1 (de)1999-06-10
ATE179710T1 (de)1999-05-15
KR920004380A (ko)1992-03-27
NO913051D0 (no)1991-08-06
NO179143B (no)1996-05-06
PT98583B (pt)1999-03-31
NO913051L (no)1992-02-10
KR100233964B1 (ko)1999-12-15
JPH0780880B2 (ja)1995-08-30
FI95909B (fi)1995-12-29
FI95909C (fi)1996-04-10
CA2046801C (en)2002-02-26
FI913754A0 (fi)1991-08-07
FI913754L (fi)1992-02-08
EP0470490A1 (en)1992-02-12

Similar Documents

PublicationPublication DateTitle
ES2132076T3 (es)Pirroles sustituidos.
ES2082755T3 (es)Derivados de acido 3-desmetil-mevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su utilizacion asi como productos intermedios.
NO170883C (no)Fremgangsmaate for fremstilling av 2-amino-5-hydroksy-4-metylpyrimidin-derivater
CU22305A3 (es)Procedimiento para la preparacion de un derivado de aminoacidos
ES2102367T3 (es)Amidas de acidos isoxazol-4-carboxilicos y amidas de acidos hidroxialquiliden-cianoaceticos, medicamentos que contienen estos compuestos y su utilizacion.
ES533901A0 (es)Perfeccionamientos en los metodos de fabricacion del acido 3-cloro-7-d-(2-fenilglicinamido)-3-cefem-4-carboxilico monohidratado
NO890408D0 (no)3-indolpyrodruesyre-derivater og deres farmasoeytiske anvendelse.
ATE105482T1 (de)Behandlung von krebs mit somatostatin und mit analogen davon.
NO173998C (no)Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
ES2010561A6 (es)Procedimiento para preparar una composicion farmaceutica a base de un analogo de somatostatina.
ATE63750T1 (de)Peptid, dessen herstellung und benutzung.
ATE74346T1 (de)Alkensaeurederivate.
NO167734C (no)Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
ES2054738T3 (es)Derivados de acido 3-desmetil-4-fluoromevalonico, procedimiento para su preparacion, preparados farmaceuticos a base de estos compuestos, su empleo y productos intermedios.
ATE83480T1 (de)Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
NO932722L (no)Salter av et 4-amino-3acyl-kinolinderivat og deres anvendelse som inhibatorer for gastrisk syresekresjon
ATE27813T1 (de)N-substituierte 1-(4'-alkylsulfonylphenyl)-2amino-1,3-propanediol-derivate.
ES2118248T3 (es)Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
DE69531554D1 (de)Verwendung von inosittriphosphat zur herstellung von arzneimitteln
BG90414A (bg)2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES2031959T3 (es)Procedimiento para preparar acidos 3,5-dihidroxicarboxilicos y sus derivados.
ES2055440T3 (es)Derivados del acido quinurenico, su preparacion y composiciones farmaceuticas que los contienen.
MX9203205A (es)Novedosos acidos dimetilamino-hidroxi-alcan-difosfonicos y sales de los mismos, en procedimiento de produccion y composiciones farmaceuticas relacionadas.
ATE77821T1 (de)Verfahren zur herstellung von penicillansaeurederivaten.
ES2073919T3 (es)Derivados de piperidina 1,3,4-trisubstituidos, su obtencion y empleo.

Legal Events

DateCodeTitleDescription
FG2ADefinitive protection

Ref document number:470490

Country of ref document:ES


[8]ページ先頭

©2009-2025 Movatter.jp